Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Tzanis

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|August 14, 2019
Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Omadacycline on QT/QTc Intervals in Healthy SubjectsBorje Darpo, Hongqi Xue, S Ken Tanaka, et al.
The Journal of Clinical Psychiatry|April 11, 2009
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorderMichael R Liebowitz, Gregory Asnis, Richard Mangano, et al.
F1000Research|June 2, 2023
Graphie: A network-based visual interface for the UK's primary legislationEvan Tzanis, Pierpaolo Vivo, Yanik-Pascal Förster, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended releaseJames M Ferguson, Arif Khan, Richard Mangano, et al.
Postgraduate Medicine|December 5, 2015
Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back painRichard L Rauck, Jeffrey Potts, Qinfang Xiang, et al.
Scientific Reports|July 15, 2021
Maximal modularity and the optimal size of parliamentsLuca Gamberi, Yanik-Pascal Förster, Evan Tzanis, et al.
Pain Medicine (Malden, Mass.)|February 27, 2016
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal BuprenorphineLynn Webster, Daniel Gruener, Todd Kirby, et al.
Psychopharmacology|June 26, 2007
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorderMark Pollack, Richard Mangano, Richard Entsuah, et al.
Journal of Clinical Pharmacology|August 20, 2016
Effect of Food on the Bioavailability of Omadacycline in Healthy ParticipantsEvan Tzanis, Amy Manley, Stephen Villano, et al.
Pain|July 20, 2016
Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal studyJoseph Gimbel, Egilius L H Spierings, Nathaniel Katz, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|August 14, 2019
Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Omadacycline on QT/QTc Intervals in Healthy SubjectsBorje Darpo, Hongqi Xue, S Ken Tanaka, et al.
The Journal of Clinical Psychiatry|April 11, 2009
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorderMichael R Liebowitz, Gregory Asnis, Richard Mangano, et al.
F1000Research|June 2, 2023
Graphie: A network-based visual interface for the UK's primary legislationEvan Tzanis, Pierpaolo Vivo, Yanik-Pascal Förster, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended releaseJames M Ferguson, Arif Khan, Richard Mangano, et al.
Postgraduate Medicine|December 5, 2015
Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back painRichard L Rauck, Jeffrey Potts, Qinfang Xiang, et al.
Scientific Reports|July 15, 2021
Maximal modularity and the optimal size of parliamentsLuca Gamberi, Yanik-Pascal Förster, Evan Tzanis, et al.
Pain Medicine (Malden, Mass.)|February 27, 2016
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal BuprenorphineLynn Webster, Daniel Gruener, Todd Kirby, et al.
Psychopharmacology|June 26, 2007
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorderMark Pollack, Richard Mangano, Richard Entsuah, et al.
Journal of Clinical Pharmacology|August 20, 2016
Effect of Food on the Bioavailability of Omadacycline in Healthy ParticipantsEvan Tzanis, Amy Manley, Stephen Villano, et al.
Pain|July 20, 2016
Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal studyJoseph Gimbel, Egilius L H Spierings, Nathaniel Katz, et al.
Pageof 4